Cargando…
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
Primary effusion lymphoma (PEL) has a very poor prognosis. To evaluate the contributions of enhancers/promoters interactions to PEL cell growth and survival, here we produce H3K27ac HiChIP datasets in PEL cells. This allows us to generate the PEL enhancer connectome, which links enhancers and promot...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726151/ https://www.ncbi.nlm.nih.gov/pubmed/33298918 http://dx.doi.org/10.1038/s41467-020-20136-w |
_version_ | 1783620823976771584 |
---|---|
author | Wang, Chong Zhang, Luyao Ke, Liangru Ding, Weiyue Jiang, Sizun Li, Difei Narita, Yohei Hou, Isabella Liang, Jun Li, Shijun Xiao, Haipeng Gottwein, Eva Kaye, Kenneth M. Teng, Mingxiang Zhao, Bo |
author_facet | Wang, Chong Zhang, Luyao Ke, Liangru Ding, Weiyue Jiang, Sizun Li, Difei Narita, Yohei Hou, Isabella Liang, Jun Li, Shijun Xiao, Haipeng Gottwein, Eva Kaye, Kenneth M. Teng, Mingxiang Zhao, Bo |
author_sort | Wang, Chong |
collection | PubMed |
description | Primary effusion lymphoma (PEL) has a very poor prognosis. To evaluate the contributions of enhancers/promoters interactions to PEL cell growth and survival, here we produce H3K27ac HiChIP datasets in PEL cells. This allows us to generate the PEL enhancer connectome, which links enhancers and promoters in PEL genome-wide. We identify more than 8000 genomic interactions in each PEL cell line. By incorporating HiChIP data with H3K27ac ChIP-seq data, we identify interactions between enhancers/enhancers, enhancers/promoters, and promoters/promoters. HiChIP further links PEL super-enhancers to PEL dependency factors MYC, IRF4, MCL1, CCND2, MDM2, and CFLAR. CRISPR knock out of MEF2C and IRF4 significantly reduces MYC and IRF4 super-enhancer H3K27ac signal. Knock out also reduces MYC and IRF4 expression. CRISPRi perturbation of these super-enhancers by tethering transcription repressors to enhancers significantly reduces target gene expression and reduces PEL cell growth. These data provide insights into PEL molecular pathogenesis. |
format | Online Article Text |
id | pubmed-7726151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-77261512020-12-17 Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors Wang, Chong Zhang, Luyao Ke, Liangru Ding, Weiyue Jiang, Sizun Li, Difei Narita, Yohei Hou, Isabella Liang, Jun Li, Shijun Xiao, Haipeng Gottwein, Eva Kaye, Kenneth M. Teng, Mingxiang Zhao, Bo Nat Commun Article Primary effusion lymphoma (PEL) has a very poor prognosis. To evaluate the contributions of enhancers/promoters interactions to PEL cell growth and survival, here we produce H3K27ac HiChIP datasets in PEL cells. This allows us to generate the PEL enhancer connectome, which links enhancers and promoters in PEL genome-wide. We identify more than 8000 genomic interactions in each PEL cell line. By incorporating HiChIP data with H3K27ac ChIP-seq data, we identify interactions between enhancers/enhancers, enhancers/promoters, and promoters/promoters. HiChIP further links PEL super-enhancers to PEL dependency factors MYC, IRF4, MCL1, CCND2, MDM2, and CFLAR. CRISPR knock out of MEF2C and IRF4 significantly reduces MYC and IRF4 super-enhancer H3K27ac signal. Knock out also reduces MYC and IRF4 expression. CRISPRi perturbation of these super-enhancers by tethering transcription repressors to enhancers significantly reduces target gene expression and reduces PEL cell growth. These data provide insights into PEL molecular pathogenesis. Nature Publishing Group UK 2020-12-09 /pmc/articles/PMC7726151/ /pubmed/33298918 http://dx.doi.org/10.1038/s41467-020-20136-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Wang, Chong Zhang, Luyao Ke, Liangru Ding, Weiyue Jiang, Sizun Li, Difei Narita, Yohei Hou, Isabella Liang, Jun Li, Shijun Xiao, Haipeng Gottwein, Eva Kaye, Kenneth M. Teng, Mingxiang Zhao, Bo Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
title | Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
title_full | Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
title_fullStr | Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
title_full_unstemmed | Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
title_short | Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
title_sort | primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726151/ https://www.ncbi.nlm.nih.gov/pubmed/33298918 http://dx.doi.org/10.1038/s41467-020-20136-w |
work_keys_str_mv | AT wangchong primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT zhangluyao primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT keliangru primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT dingweiyue primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT jiangsizun primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT lidifei primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT naritayohei primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT houisabella primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT liangjun primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT lishijun primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT xiaohaipeng primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT gottweineva primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT kayekennethm primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT tengmingxiang primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors AT zhaobo primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors |